Showing 1081-1090 of 1281 results for "".
- EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officerhttps://modernod.com/news/eyepoint-pharmaceuticals-appoints-isabelle-lefebvre-as-chief-regulatory-officer/2480678/EyePoint Pharmaceuticals announced the appointment of Isabelle Lefebvre as Chief Regulatory Officer. Ms. Lefebvre brings more than 30 years of global regulatory affairs experience across all phases of drug development, including ophthalmic and ocular conditions. Ms. Lefebvre is su
- Glauconix Biosciences Promotes Kimberly Southern to Chief Executive Officerhttps://modernod.com/news/glauconix-biosciences-promotes-kimberly-southern-to-chief-executive-officer/2477262/Glauconix Biosciences announced that its board of directors has appointed Kim Southern as Chief Executive Officer and a member of the Board of Directors effective immediately. Ms. Southern previously held the position of Chief Operating Officer. Since joining the company in May, Ms. Southe
- Three Optometric Practices in Florida Partner With US Eyehttps://modernod.com/news/us-eye-expands-into-now-5-states-50-clinics-and-5-ascs-100-providers-and-1000-team-members/2480526/Three optometric practices in Florida have partnered with US Eye. The new partnerships include Rick Billings, OD; Hart Eye Care; and Precision Eye Care of Central Florida.
- Orbis International Appoints Kathleen Sherwin as New President and CEOhttps://modernod.com/news/orbis-international-appoints-kathleen-sherwin-as-new-president-and-ceo/2485326/Global nonprofit organization Orbis International has named Kathleen Sherwin as its new President and Chief Executive Officer, effective immediately. Ms. Sherwin arrives at Orbis with more than 25 years of leadership experience
- Eversight Names Diane Hollingsworth President/CEOhttps://modernod.com/news/eversight-names-diane-hollingsworth-president-ceo/2479171/Eversight announced that Diane Hollingsworth has been named President/CEO of the nonprofit eye bank network, effective immediately. Ms. Hollingsworth has served as interim President/CEO s
- Lensar Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. O’Farrellhttps://modernod.com/news/lensar-expands-board-of-directors-with-the-appointments-of-aimee-s-weisner-and-elizabeth-g-ofarrell/2478817/Lensar announced the expansion of its board of directors to seven members with the appointments of Aimee S. Weisner and Elizabeth G. O’Farrell, effective February 1, 2021. In addition to serving on the company’s Board of Directors, Ms. Weisner will
- Orbis International Announces Mary Jane Jamar as First Chief Human Resources Officerhttps://modernod.com/news/orbis-international-announces-mary-jane-jamar-as-first-chief-human-resources-officer/2478605/Orbis has named Mary Jane Jamar as the organization’s first Chief Human Resources Officer (CHRO). In this capacity, Ms. Jamar will also join and play a critical role on the Orbis Executive Leadership Team.
- PolyActiva Appoints Tracy Valorie to its Board of Directorshttps://modernod.com/news/polyactiva-appoints-tracy-valorie-to-its-board-of-directors/2478481/PolyActiva announced the appointment of experienced ophthalmic industry expert, Tracy Valorie, as a new member to the company’s Board of Directors. Ms. Valorie is recognized in the industry for her success in building and leading high performing teams a
- ATPO Announces Jessica Barr as New Presidenthttps://modernod.com/news/atpo-announces-jessica-barr-as-new-president/2476160/The Association of Technical Personnel in Ophthalmology (ATPO) has announced that Jessica Barr, COMT, ROUB, is its new president. Ms. Barr is an Implementation Specialist and Education Liaison fo
- Aurion Makes Leadership Announcementshttps://modernod.com/news/aurion-makes-leadership-announcements/2482757/Aurion Biotech announced the appointments of Edward J. Holland, MD, as Chief Medical Officer, and Eris P. Jordan, OD, as Chief Development Officer. Aurion is developing AURN001, an investigational, single-administration, allogeneic cell therapy for the treatment of corneal edema seconda